Author

Anindita Bhattacharjee

University of KalyaniPrimary ORCID profile (0000-0002-9289-8887 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Anindita BhattacharjeeiD3 papers · The University of Texas at San Antonio Health Science Center

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Arijit BhattacharyaiD· 1 shared Arka BagchiiD· 1 shared Arunima BiswasiD· 1 shared Solanki Sarkar· 1 shared Sriparna BawaliiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Arijit BhattacharyaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases

Anindita Bhattacharjee, Arka Bagchi, Solanki Sarkar, Sriparna Bawali, Arijit Bhattacharya, Arunima Biswas

This study identifies sorafenib and imatinib as potential anti-leishmanial drugs by targeting Leishmania MAP kinases, showing anti-proliferative effects and reduced parasitic burden.

Life Sciences · Jun 17, 2024Peer-reviewedBioinformatics